Arif, Mohammed http://orcid.org/0000-0001-5741-8860
Nabavizadeh, Pooneh
Song, Taejeong
Desai, Darshini
Singh, Rohit
Bazrafshan, Sholeh
Kumar, Mohit
Wang, Yigang
Gilbert, Richard J.
Dhandapany, Perundurai S.
Becker, Richard C.
Kranias, Evangelia G.
Sadayappan, Sakthivel
Funding for this research was provided by:
American Heart Association (19UFEL34380251, 17CCRG33671128)
American Heart Association (15CVGPSD27020012)
National Heart, Lung, and Blood Institute (HL130356, HL139680)
National Heart, Lung, and Blood Institute (HL105826)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR067279)
American Historical Association (19TPA34830084)
Article History
Received: 30 June 2020
Accepted: 3 July 2020
First Online: 12 July 2020
Compliance with ethical standards
:
: Dr. Sadayappan provides consulting and collaborative research studies to the Leducq Foundation (CURE-PLAN), Red Saree Inc., Greater Cincinnati Tamil Sangam, AstraZeneca, MyoKardia, Merck, and Amgen, but such work is unrelated to the content of this manuscript. Dr. Becker serves on scientific advisory boards for following: Janssen and DSMB Committees for Ionis Pharmaceuticals, Akcea Therapeutics, and Novartis. Dr. Singh has been a post-doctoral fellow of Amgen, starting from June, 2019 and performs research at the University of Cincinnati. No other disclosures are reported.